SHR4640
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for SHR4640, covering 2017-02-28 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia [Phase 2]